A better understanding of how the NRF2/Keap1 axis functions at the molecular level and how it connects to the glutamatergic pathway in melanoma may help uncover novel regulatory mechanisms of GLS-mediated tumorigenesis. The gene discussed is KEAP1; the disease is melanoma.